18-FDG PET/CT

DEVICE2 trials

Sponsors

National Cancer Institute (NCI), The European Uro-Oncology Group

Conditions

Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaProstate Cancer MetastaticSmoldering Multiple Myeloma

Phase 2

Imaging in MGUS, SMM and MM

CompletedNCT01237054

National Cancer Institute (NCI)Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma

Start: 2010-10-17End: 2011-08-09Updated: 2026-02-06

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

CompletedNCT02814968

The European Uro-Oncology GroupProstate Cancer Metastatic

Start: 2015-02-28End: 2020-12-31Updated: 2022-04-14

Related Papers

Focal bone marrow processes and early bone lesions in patients with multiple myeloma (MM) precursor diseases: A prospective study using molecular imaging.

Journal of Clinical Oncology2014-05-20